Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kewei Chen

Showing results (501-510 of 511) with videos related to

Pageof 52
Sort By:
The Lancet. Neurology|January 24, 2026
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trialPierre N Tariot, Francisco S Lopera, Silvia Ríos-Romenets, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Journal of Alzheimer'S Disease : JAD|November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementiaJulie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Colin Groot, Willemijn J Jansen, et al.
JAMA Psychiatry|December 1, 2017
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J Jansen, Rik Ossenkoppele, Betty M Tijms, et al.
JAMA Psychiatry|January 22, 2025
Depressive Symptoms and Amyloid PathologyWietse A Wiels, Julie E Oomens, Sebastiaan Engelborghs, et al.
JAMA|May 20, 2015
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysisWillemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, et al.
JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humansTrygve E Bakken, J Cooper Roddey, Srdjan Djurovic, et al.
Pageof 52

Showing results (501-510 of 511) with videos related to

Sort By:
Pageof 52
The Lancet. Neurology|January 24, 2026
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trialPierre N Tariot, Francisco S Lopera, Silvia Ríos-Romenets, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Journal of Alzheimer'S Disease : JAD|November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementiaJulie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Colin Groot, Willemijn J Jansen, et al.
JAMA Psychiatry|December 1, 2017
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J Jansen, Rik Ossenkoppele, Betty M Tijms, et al.
JAMA Psychiatry|January 22, 2025
Depressive Symptoms and Amyloid PathologyWietse A Wiels, Julie E Oomens, Sebastiaan Engelborghs, et al.
JAMA|May 20, 2015
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysisWillemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, et al.
JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humansTrygve E Bakken, J Cooper Roddey, Srdjan Djurovic, et al.
Pageof 52